Cited 0 times in Scipus Cited Count

A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)

DC Field Value Language
dc.contributor.authorPark, YH-
dc.contributor.authorKim, TY-
dc.contributor.authorKim, GM-
dc.contributor.authorJung, KH-
dc.contributor.authorKang, SY-
dc.contributor.authorPark, IH-
dc.contributor.authorKim, JH-
dc.contributor.authorLee, KE-
dc.contributor.authorAhn, HK-
dc.contributor.authorLee, MH-
dc.contributor.authorKim, HJ-
dc.contributor.authorKim, HJ-
dc.contributor.authorLee, JI-
dc.contributor.authorKoh, SJ-
dc.contributor.authorKim, JY-
dc.contributor.authorLee, KH-
dc.contributor.authorSohn, J-
dc.contributor.authorKim, SB-
dc.contributor.authorIm, YH-
dc.contributor.authorIm, SA-
dc.date.accessioned2022-01-14T05:17:03Z-
dc.date.available2022-01-14T05:17:03Z-
dc.date.issued2019-
dc.identifier.issn0732-183X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/19984-
dc.titleA randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)-
dc.typeArticle-
dc.contributor.affiliatedAuthorKang, SY-
dc.type.localJournal Papers-
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.1007-
dc.citation.titleJournal of clinical oncology-
dc.citation.volume37-
dc.citation.number15_suppl-
dc.citation.date2019-
dc.citation.startPage1007-
dc.citation.endPage1007-
dc.identifier.bibliographicCitationJournal of clinical oncology, 37(15_suppl). : 1007-1007, 2019-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1527-7755-
dc.relation.journalidJ00732183X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse